ESP 818 Pill - blue oval, 15mm
Generic Name: bempedoic acid/ezetimibe
Pill with imprint ESP 818 is Blue, Oval and has been identified as Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg. It is supplied by Esperion Therapeutics, Inc.
Nexlizet is used in the treatment of Cardiovascular Risk Reduction; High Cholesterol, Familial Heterozygous; High Cholesterol and belongs to the drug class antihyperlipidemic combinations. Nexlizet bempedoic acid 180 mg / ezetimibe 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ESP 818
Nexlizet
- Generic Name
- bempedoic acid/ezetimibe
- Imprint
- ESP 818
- Strength
- bempedoic acid 180 mg / ezetimibe 10 mg
- Color
- Blue
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antihyperlipidemic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Esperion Therapeutics, Inc.
- National Drug Code (NDC)
- 72426-0818
More about Nexlizet (bempedoic acid/ezetimibe)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
